|Previous Section||Index||Home Page|
Steve Webb: To ask the Secretary of State for Health how much her Department spent on (a) drug treatments and (b) therapeutic treatments for mild to severe depression in each year from 1997 to 2005 (i) in total and (ii) broken down by age. 
|Table 1:- NHS anti-depressant prescription medications in England 1997 to 2005|
|Value of antidepressant items prescribed on the NHS in England (£000)|
| Source: Prescription pricing authority of the Business Services Authority (formerly known as the Prescription Pricing Authority)|
Age-based prescription data covering all age groups are not available. This information is collected for groups where prescription charge exemptions existthose aged zero to 15 years and 16 to 18 years and those in full-time education and people aged 60 or overbut not for other age categories.
Information about spending on psychological therapies by the national health service in England is available for each year from 2001-02 to 2004-05 from the national survey of investment in mental health services reports, and this is shown in Table 2. Information about spending on psychological therapies which were delivered in primary care is not held centrally by the Department; nor is information collected on spending on psychological therapies by age groups.
|Table 2: National survey of investment in mental health services: planned spending on psychological therapies|
|Planned spending on psychological therapy services by the NHS in England 2001-02 to 2005-06 (not primary care) (£000)|
|Source: National survey of investment in mental health strategies 2001-02 to 2005-06|
Steve Webb: To ask the Secretary of State for Health, pursuant to her Department's publication of data on diagnostic tests' waiting times, if she will publish overall waiting times for patients from GP referral to the start of treatment. 
Mr. Lansley: To ask the Secretary of State for Health, pursuant to the answer of 27 June 2006, Official Report, column 323W, on diagnostic treatment (independent sector), what the reasons are for the delay in the start date beyond that set out in Health reform in England: Update and Next Steps, published 13 December 2005. 
Mr. Ivan Lewis: Discussions are drawing to a close with bidders on all seven regional diagnostic schemes. Full services are expected to be provided from next year, but the first scheme may begin to provide some services from November 2006. The commencement date has moved from October to better meet local national health service needs.
Mr. Bone: To ask the Secretary of State for Health what discussions she has had on the potential for using poppies grown in Afghanistan to alleviate the shortage of diamorphine hydrochloride for medical use. 
Andy Burnham: None. The shortage of diamorphine injection is due to production capacity constraints in relation to the finished product, and is not related to the availability of diamorphine raw material. There are no supply problems with diamorphine raw material.
Dr. Desmond Turner:
To ask the Secretary of State for Health what the rate of use of (a) drug eluting and
(b) bare metal stents is in the NHS; and what assessment she has made of the effect on costs in the NHS of their use. 
Since the National Institute for Health and Clinical Excellence (NICE) published its guidance on the use of coronary artery stents in October 2003 there has been an increase in the use of drug eluting stents. This increase has been reflected by an adjustment to the national tariff of £25.5 million in 2006-07 to take account of the additional costs of implementing the NICE guidance.
John Cummings: To ask the Secretary of State for Health how many (a) residential and (b) in-patient- specialist drug treatment rehabilitation places there are in the northern region; and where each centre is located. 
Caroline Flint: As there is no northern region as such, the following information represents the North West, North East and Yorkshire and Humber Government regions. Information relating to numbers of in-patient beds and treatment spaces is not available for any of these areas.
The National Treatment Agency's (NTA) online directory of residential rehabilitation services lists a total of 19 services located in the north west. The total number of beds in all of these services is 320.
The services are located in Crumpsall, Oldham, Wirral, two services; Ramsbottom, Chester, two services; Gisburn, two services; St Anne's on Sea, two services; Lancaster, Prestwich, Middleton, Collyhurst, Blackburn, Rochdale and Workington.
The NTA's recently published review of in-patient treatment, Dr. Ed Day, 2005, found a total of 16 services providing in-patient treatment for drug misuse in the north west. These services are located in Oxton, Macclesfield, Gisburn, two services; Lancaster, Carlisle, Liverpool, Prestwich, Chester, two services; St Anne's on Sea, Biston, Hale, Preston, Ashton under Lyme and Collyhurst.
The NTA's recently-published review of in-patient treatment, Dr. Ed Day, 2005, found a total of 14 services providing in-patient treatment for drug misuse in Yorkshire and Humber. These services are located in Barnsley, York, Sheffield, three services, Bradford, two services, Harrogate, Doncaster, Scarborough, Northallerton, Dewsbury, Rotherham and Whitby.
|Estimated list price cost (£ billion) of medicines issued in hospitals in England|
|List price cost (£ billion)|
The information in the table does not take into account medicines prescribed in hospitals but dispensed in the community (on a FP10 HP form) or drugs dispensed in the community, primary care, in England.
The estimated list price costs are based on published prices from the drug tariff and other standard price
lists. Therefore this is not a true reflection of the actual expenditure by hospitals as most purchases are made on contract with individual manufacturers or wholesalers at lower prices.
Ms Rosie Winterton: The Department has not undertaken any specific recent work to define future demand for echocardiography services. However, there is a national target that by 2008 all patients will be treated within 18 weeks of general practitioner referral, and this will include diagnostics such as echocardiography. Reducing waiting times for diagnostics is central to delivering the 18-week patient pathway. The national health service began measuring waiting times for long wait diagnostic tests for the first time this year to assess the scale of the 18-week challenge.
Andy Burnham: The 18-week work force resource pack was published in April 2006 and can be found at www.18weeks.nhs.uk. Copies have been placed in the Library. The pack includes support and advice on work force modelling (known as Christmas trees) for the 18-week work force including elective care and diagnostics (imaging, endoscopy, physiological measurement and pathology).
|Next Section||Index||Home Page|